Acorda Therapeutics, Inc. Gains 25.83%
Mon, Nov 02, 2020 at 05:30 PM
Acorda Therapeutics, Inc. (ACOR:NASDAQ) rocketted at $1.1, representing a gain of 25.8%. The stock appeared on our News Catalysts scanner on Mon 26 Oct 20 at 05:35 PM in the 'EARNINGS' category. From Fri 16 Oct 20, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Tue 20 Oct 20 at $1.64 with a volume of 110M+.
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- Endurance International Group Holdings, Inc. (EIGI:NASDAQ), 61.96%
- Superior Industries International, Inc. (SUP:NYSE), 60.16%
- Digital Ally, Inc. (DGLY:NASDAQ), 32.75%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 25.83%
- Par Pacific Holdings, Inc. (PARR:NYSE), 23.29%
- Renren Inc. (RENN:NYSE), 23.24%
- DBV Technologies S.A. (DBVT:NASDAQ), 23.08%
- Insignia Systems, Inc. (ISIG:NASDAQ), 22.88%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 22.12%
- TimkenSteel Corporation (TMST:NYSE), 18.6%